Bacterin International Holdings Inc  

(Public, NYSEMKT:BONE)   Watch this stock  
Find more results for NYSEAMEX:BONE
0.691
0.000 (0.00%)
Apr 24 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 0.69 - 0.72
52 week 0.37 - 1.41
Open 0.72
Vol / Avg. 267,194.00/687,578.00
Mkt cap 37.91M
P/E     -
Div/yield     -
EPS -0.26
Shares 54.86M
Beta 2.65
Inst. own 22%
May 7, 2014
Q1 2014 Bacterin International Holdings Inc Earnings Conference Call - 10:00AM EDT - Add to calendar
May 6, 2014
Q1 2014 Bacterin International Holdings Inc Earnings Release - 4:00PM EDT - Add to calendar
Mar 20, 2014
Q4 2013 Bacterin International Holdings Inc Earnings Conference Call
Mar 19, 2014
Q4 2013 Bacterin International Holdings Inc Earnings Release
Mar 11, 2014
Bacterin International Holdings Inc at Canaccord Genuity's Musculoskeletal Conference
Feb 13, 2014
Bacterin International Holdings Inc at Leerink Swann Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -50.43% -38.38%
Operating margin -43.11% -27.24%
EBITD margin - -22.75%
Return on average assets -55.75% -40.06%
Return on average equity - -6505.79%
Employees 128 -
CDP Score - -

Address

600 Cruiser Lane
BELGRADE, MT 59714
United States - Map
+1-406-3880480 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bacterin International Holdings Inc is a United States-based tissue bank and medical device company. The Company designs, processes, manufactures, and markets advanced medical products. Its a specialty tissue bank focused on processing and distributing allografts to the patients. It utilizes BacteRinse Sterile Technology to process its allografts. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM Putty, OsteoWrap, OrbitalWrap HD, Facet Stabilization, Milled Cervical Spacers, Traditional Allografts, hMatrix ADM, hMatrix PR ADM, Sports Medicine, Elutia Wound Drains and OsteoSTX.

Officers and directors

Kent L. Swanson Independent Acting Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Daniel S. Goldberger President, Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
John P. Gandolfo Interim Co-Chief Executive Officer, Chief Financial Officer
Age: 52
Bio & Compensation  - Reuters
Darrel Lee Holmes Interim Co-Chief Executive Officer, Chief Operating Officer
Age: 60
Bio & Compensation  - Reuters
Gregory A. Juda PhD Chief Scientific Officer
Age: 37
Bio & Compensation  - Reuters
Nicholas Maxwell Navarro National Sales Manager
Age: 33
Bio & Compensation  - Reuters
John Deedrick Director
Age: 50
Bio & Compensation  - Reuters
Mitchell T. Godfrey Director
Age: 67
Bio & Compensation  - Reuters
Michael A. Lopach Independent Director
Age: 64
Bio & Compensation  - Reuters
Jon M. Wickwire Independent Director
Age: 69
Bio & Compensation  - Reuters